Every few months for the past three years, Jeff Vierstra has been receiving infusions in his spine that target and disable a mutated gene that made it likely he would develop ALS.
from Us - CBSNews.com https://ift.tt/cLQg2fy
via IFTTT
from Us - CBSNews.com https://ift.tt/cLQg2fy
via IFTTT
Comments
Post a Comment